Background: An increased risk of breast cancer has been observed in night shift workers. Exposure to artificial light at night and disruption of the endogenous circadian rhythm with suppression of the melatonin synthesis have been suggested mechanisms. We investigated the hypothesis that rotating night shift work is associated with mammographic density.

Methods: We conducted a cross-sectional study on the association between rotating night shift work characteristics, 6-sulfatoxymelatonin (MT6s) creatinine adjusted in a spot morning urine sample, and a computer-assisted measure of mammographic density in 640 nurses and midwives ages 40 to 60 years. The associations were evaluated using regression models adjusted for age, body mass index, menopausal status, age at menopause, age at menarche, smoking, and the calendar season of the year when mammography was conducted.

Results: The adjusted means of percentage of mammographic density and absolute density were slightly higher among women working rotating night shifts but not statistically significant [percentage of mammographic density = 23.6%, 95% confidence interval (CI), 21.9%–25.4% vs. 22.5%, 95% CI, 20.8%–24.3%; absolute density = 23.9 cm2, 95% CI, 21.4–26.4 cm2 vs. 21.8 cm2, 95% CI, 19.4–24.3 cm2 in rotating night shift and day shift nurses, respectively). There were no significant associations between the current or cumulative rotating night shift work exposure metrics and mammographic density. No association was observed between morning MT6s and mammographic density.

Conclusions: The hypothesis on the link between rotating night shift work, melatonin synthesis disruption, and mammographic density is not supported by the results of the present study.

Impact: It is unlikely that the development of breast cancer in nurses working rotating night shifts is mediated by an increase in mammographic density. Cancer Epidemiol Biomarkers Prev; 21(7); 1028–37. ©2012 AACR.

This article is featured in Highlights of This Issue, p. 997

Night shift work has been classified by the International Agency for Research on Cancer (Lyon, France) as a probable carcinogen (1). This classification was based on the evidence from experimental studies on animals that showed carcinogenicity of artificial light during the dark period (biologic night), combined with limited evidence from studies in humans on cancer risks associated with shift work that involves night work. Eight (2–9) of 12 epidemiologic studies (2–13) that have addressed this topic have reported a statistically significant association between night shift work and the risk of breast cancer. The biologic mechanisms underlying the increased breast cancer risk in night shift workers have not been fully recognized yet, nevertheless, sleep deprivation, disruption of the circadian rhythm, dysregulation of the circadian rhythm genes, and inhibition of melatonin synthesis have been suggested as potential explanations (14–16). An inverse association between melatonin and breast cancer risk has been observed in some (17–20), but not all, prospective epidemiologic studies (17–21).

Melatonin, a pineal gland hormone, has been found to act as an inhibitor of tumor cell proliferation in animal models and in human cancer cells lines (22). Its anticarcinogenic properties have been explained by its antiestrogenic and antioxidative activity, stimulation of the immune system, and its role in the cell-cycle regulation (23).

Mammographic density reflects the tissue composition of the breast and is positively associated with the amount of collagen and the number of epithelial and nonepithelial cells and negatively associated with fat (24). It has been found to be a strong and independent risk factor of breast cancer, with a 4.6-fold increased breast cancer risk observed in women with extensive (>75%) percentage of mammographic density, when compared with women with a small proportion of dense areas in the breast (<5%; ref. 25).

Given the observations of an increased risk of breast cancer in night shift workers, it could be hypothesized that prolonged night shift work, through melatonin-related mechanisms or other mechanisms, may possibly influence mammographic density. To test this hypothesis, we set up a cross-sectional study examining the association between night shift work history and mammographic density in nurses. In addition, we tested the association between 6-sulfatoxymelatonin (MT6s; melatonin metabolite), as a biomarker of circadian rhythm disruption, and mammographic density.

This cross-sectional study included nurses and midwives registered at the Local Registry of the Chamber of Nurses and Midwives in Lodz, Poland. A total of 1,117 nurses and midwives was randomly selected for the study, based on the registry database (i.e., ∼30% of the registered in this age group), and of these, 924 (83%) were contacted. Inclusion criteria (age 40–60 and current employment as a nurse in public health care setting in Lodz) were confirmed for 866 women, and 725 (84% of the eligible subjects) women agreed to participate in the study.

A structured questionnaire was administered during in-person interviews, and information was obtained on occupational history, demographics, medical and reproductive history, hormone use, physical activity (according to the international questionnaire on physical activity, IPAQ; ref. 26), smoking and alcohol use, diet, and sleep quality (according to Pittsburg Sleep Quality Questionnaire; ref. 27). Body weight and height, hip and waist circumferences were measured.

Of 725 women who agreed to participate in the study, 681 (i.e., 95%) had undergone screening mammogram. As many as 41 took hormonal medications for menopause symptoms at the time of the mammography and were excluded, leaving 640 women for the analysis.

Digital mammography was conducted with MAMMOMAT Novation DR, Siemens, Munich, the Federal Republic of Germany, according to the standard procedure in the Center of Laser Diagnostics and Treatment of the Technical University in Lodz. The examination of the breasts included both craniocaudal and mediolateral oblique views. The mean time between urine collection and mammography was 130 days, and in 462 women (72%), mammographic examination was conducted within 6 months of the interview.

The study was approved by the Ethical Institutional Review Board at the Nofer Institute of Occupational Medicine (Lodz, Poland). A signed informed consent was obtained from each study participant.

Mammographic density assessment

Left breast craniocaudal views were used for the mammographic density assessment. The images were transformed to .jpg files using the ImageMagick Program (Magick Studio LLC) with the resolution of 832 × 1,021 pixels. The University of Southern California (Los Angeles, CA) Madena computer program was used to determine mammographic density. The method has been previously described and validated (28, 29). The total dense area − absolute density (in cm2) and percentage of density (calculated as the ratio of the dense area to the total breast area) were estimated. The percentage of mammographic density, or the fraction of the breast with densities, is the ratio of absolute density to the total breast area. The density assessments were conducted by G. Ursin and the outline assessments by A. Bukowska.

For the reproducibility assessment, the total breast area and the dense areas readings were repeated for 10% of the images, randomly selected from the database, ensuring blindness of the readers in respect of the subjects' identifiers as well as the previous readings results. The test-retest estimates were highly correlated, with R = 0.98 (P < 0.00001) for both the total breast area and the dense areas estimates.

Breast mammograms were also examined by radiologists who classified the images according to the BI-RADS classifications (30). A comparison of the 2 methods was carried out with Kendall correlation test, resulting with τ = 0.69 (P < 0.0001).

Urine samples collection and MT6s analysis

The procedures of urine sample collection and analyses have been described previously (31). In short, the participants provided a spot morning urine sample (6–8 am). In the case of night shift workers, the urine sample was taken at the end of the night shift. The samples were collected by trained nurses and delivered to the laboratory immediately. They were frozen at −20°C in the laboratory and stored until analysis. Immediately before the analysis, thawed samples were centrifuged, and the supernatant was used for MT6s determination.

We analyzed MT6s using an ELISA test (DRG International, Inc.). The MT6s levels were creatinine-adjusted to account for the differences in the urine concentration. Creatinine levels were measured in the urine using a colorimetric method (Alpha Diagnostics). The analyses were conducted according to the manufacturer's specification.

The average within the batch coefficient of variation was 8.13% and 11.57% (control urine with a low and high MT6 level, respectively) for urinary MT6s and 1.60% and 1.91% for control urine with a low and high creatinine level, respectively. Assay reliability was assessed with Pearson correlation coefficients for 76 paired measurements of morning MT6s adjusted for the creatinine levels, with R2 = 0.96 (P < 0.0001).

Night shift work exposure assessment

The occupational data collected by means of the questionnaire included information on the current job and every previous job conducted for at least half a year. Night shift work history was analyzed using the following characteristics: the total duration of jobs with night shift work, the cumulative number of night shift hours over the entire work history, the cumulative number of night shifts, and the average frequency of night shifts weighted by the duration of the jobs. The current job characteristics were analyzed with the following variables specified: current rotating night shift work (yes/no), night shift work frequency (per month), activities conducted during the duty, duration of effective working hours during a night shift—after subtracting the time of breaks/napping from the total duration of the night shift, and light at night. Finally, the total duration of exposure to surgical lamp was calculated.

Statistical analysis

The primary goal of our analyses was to assess whether night shift work was related to mammographic density. Two measures of mammographic density were used, percentage of mammographic density and absolute density. The distribution of both of them was skewed with a long right tail. To satisfy the assumptions of the linear regression model, a square root transformation was applied to the absolute density measure. Calculated means were back-transformed. Linear regression models were used to assess the association between absolute density and night shift work. Because percentage of density expresses proportions and takes values between 0% and 100% on a continuous scale, we followed the strategy developed by Ferrari and Cribari-Neto and beta regression model was fitted (32). The goodness of fit of this model was better when compared with gauss or gamma models [Akaike information criterion (AIC); ref. 33]. Percentage of mammographic density was scaled to (0, 1) interval. Because the model requires values within the interval 0 < y < 1, for 7 women who had percentage of mammographic density values = “0,” we imputed half of the smallest value occurring in the data set (i.e., 0.00015935).

On the basis of the existing knowledge on the potential factors associated with mammographic density or melatonin synthesis, an initial list of potential confounders was formulated. Associations of these factors with percentage of mammographic density and absolute density were tested in univariate regression analyses. All the variables that passed the significance level (P > 0.20) were examined in the multivariate models (34). Covariates that changed the estimates of an association between absolute density or percentage of mammographic density and any of the night shift work characteristics by at least 10% were included in the final analysis, in particular: age (in years), body mass index (BMI; kg/m2; continuous inversed values), menopausal status (premenopausal for women with periods, and postmenopausal if no menstruation occurred during the recent 12 months), age at menopause (<50, ≥50 years), age at menarche (continuous), smoking (current, past, never smokers), and the calendar season of the year when mammography was conducted (summer, autumn, winter, spring). Other characteristics were also tested, but they were not included in the final models, in particular parity (0, 1, 2, 3+), age at first birth in parous women (≤24, >24–<30, ≥ 30), family history of breast cancer (yes/no), oral contraceptives or sex hormones use (ever, never), alcohol drinking (drinks per week), physical activity [expressed in metabolic equivalents (MET) h/wk according to the standard IPAQ method], and additionally in MT6s analysis: season of the year of urine collection (March–September vs. October–February).

Analyses on cumulative exposure to night shift work were conducted in the total population and in the subgroup of women working currently night shifts. No major differences were observed and, therefore, the results for the total population are presented.

To explore the potentially modifying effect of the menopausal status or BMI, we conducted stratified analyses in premenopausal and postmenopausal women and in the categories of BMI, according to WHO classification (normal weight BMI in the range 18.5–24.99 and overweight and obese combined BMI > 24.99). The statistical significance of the effect modifier was tested using the likelihood ratio test (34). No heterogeneity of the associations was seen.

To explore the association between morning MT6s levels and mammographic percentage density, we categorized MT6s concentrations into quartiles. A linear regression model and beta regression models were fitted with absolute density and percentage density as dependent variables, respectively, and MT6s and a set of covariates described above as independent variables.

Statistical analyses were run using STATA Version 11 (StataCorp LP). All P values are 2-sided. P values less than 0.05 were considered statistically significant.

The basic characteristics of the total research population and in the subgroups by the current night shift work status are presented in Table 1. The group of women currently working rotating night shifts was slightly younger, with more premenopausal women, when compared with the group of nurses working during the days only. More than 90% of the women currently working rotating night shifts had conducted such work for longer than 15 years. Among the women currently working day shifts, slightly more than 30% reported working night shifts for more than 15 years and 83% of them had resigned from night shifts more than 5 years before the starting point of our study.

Table 1.

Selected characteristics of the nurses and midwives with screening mammography in the cross-sectional study

Total population (n = 640)Rotating nights (n = 321)Day shifts (n = 319)
Characteristicsn (%)Mean (SD)n (%)Mean (SD)n (%)Mean (SD)
Age,a 49.0 (5.4)  48.1 (5.2)  50.0 (5.4) 
Menopausal status       
 Pre 368 (57.5)  206 (64.0)  162 (51.0)  
 Post 272 (42.5)  115 (36.0)  157 (49.0)  
Age at menopause (in postmenopausal),b 49.3 (3.9)  48.8 (3.9)  49.6 (4.1) 
Age at menarche,b 13.2 (1.5)  13.3 (1.4)  13.0 (1.6) 
Number of full-term births       
 0 76 (11.9)  39 (12.1)  37 (11.6)  
 1 215 (33.6)  101 (31.5)  114 (35.7)  
 2 313 (48.9)  156 (48.6)  157 (49.2)  
 3–4 36 (5.6)  25 (7.8)  11 (3.5)  
Age at first full-term birth (≥37 wk), y       
 ≤24 319 (56.6)  159 (56.4)  160 (56.7)  
 >24–<30 188 (33.3)  91 (32.3)  97 (34.4)  
 ≥30 57 (10.1)  32 (11.3)  25 (8.9)  
Family history of breast cancerb       
 No 587 (91.7)  292 (91.0)  295 (92.5)  
 Yes 51 (8.0)  27 (8.4)  24 (7.5)  
BMI, kg/m2  27.2 (4.7)  27.1 (4.7)  27.2 (4.7) 
Smoking       
 Current 188 (29.4)  106 (33.0)  82 (25.7)  
 Past 173 (27.0)  77 (24.0)  96 (30.1)  
 Nonsmokers 279 (43.6)  138 (43.0)  141 (44.2)  
Ever oral contraceptives or sex hormones use       
 Yes 153 (23.9)  74 (23.0)  79 (24.8)  
 No 487 (76.1)  247 (77.0)  240 (75.2)  
Calendar season of mammography       
 Summer 135 (21.1)  63 (19.6)  72 (22.6)  
 Autumn 251 (39.2)  129 (40.2)  122 (38.2)  
 Winter 101 (15.8)  47 (14.6)  54 (16.9)  
 Spring 153 (23.9)  82 (25.6)  71 (22.3)  
Total duration of the night shift work,a      
 ≤5 77 (12.0)  3 (0.9)  74 (23.2)  
 >5–≤15 163 (25.5)  26 (8.1)  137 (43.0)  
 >15–≤25 234 (36.6)  145 (45.2)  89 (27.9)  
 >25 166 (25.9)  147 (45.8)  19 (5.9)  
Arithmetic mean − percentage of mammographic density (SD)  23.2 (20.0)  24.5 (20.4)  22.0 (19.6) 
Arithmetic mean − absolute area dense, cm2 (SD)  28.1 (26.9)  30.0 (28.4)  26.2 (25.2) 
Total population (n = 640)Rotating nights (n = 321)Day shifts (n = 319)
Characteristicsn (%)Mean (SD)n (%)Mean (SD)n (%)Mean (SD)
Age,a 49.0 (5.4)  48.1 (5.2)  50.0 (5.4) 
Menopausal status       
 Pre 368 (57.5)  206 (64.0)  162 (51.0)  
 Post 272 (42.5)  115 (36.0)  157 (49.0)  
Age at menopause (in postmenopausal),b 49.3 (3.9)  48.8 (3.9)  49.6 (4.1) 
Age at menarche,b 13.2 (1.5)  13.3 (1.4)  13.0 (1.6) 
Number of full-term births       
 0 76 (11.9)  39 (12.1)  37 (11.6)  
 1 215 (33.6)  101 (31.5)  114 (35.7)  
 2 313 (48.9)  156 (48.6)  157 (49.2)  
 3–4 36 (5.6)  25 (7.8)  11 (3.5)  
Age at first full-term birth (≥37 wk), y       
 ≤24 319 (56.6)  159 (56.4)  160 (56.7)  
 >24–<30 188 (33.3)  91 (32.3)  97 (34.4)  
 ≥30 57 (10.1)  32 (11.3)  25 (8.9)  
Family history of breast cancerb       
 No 587 (91.7)  292 (91.0)  295 (92.5)  
 Yes 51 (8.0)  27 (8.4)  24 (7.5)  
BMI, kg/m2  27.2 (4.7)  27.1 (4.7)  27.2 (4.7) 
Smoking       
 Current 188 (29.4)  106 (33.0)  82 (25.7)  
 Past 173 (27.0)  77 (24.0)  96 (30.1)  
 Nonsmokers 279 (43.6)  138 (43.0)  141 (44.2)  
Ever oral contraceptives or sex hormones use       
 Yes 153 (23.9)  74 (23.0)  79 (24.8)  
 No 487 (76.1)  247 (77.0)  240 (75.2)  
Calendar season of mammography       
 Summer 135 (21.1)  63 (19.6)  72 (22.6)  
 Autumn 251 (39.2)  129 (40.2)  122 (38.2)  
 Winter 101 (15.8)  47 (14.6)  54 (16.9)  
 Spring 153 (23.9)  82 (25.6)  71 (22.3)  
Total duration of the night shift work,a      
 ≤5 77 (12.0)  3 (0.9)  74 (23.2)  
 >5–≤15 163 (25.5)  26 (8.1)  137 (43.0)  
 >15–≤25 234 (36.6)  145 (45.2)  89 (27.9)  
 >25 166 (25.9)  147 (45.8)  19 (5.9)  
Arithmetic mean − percentage of mammographic density (SD)  23.2 (20.0)  24.5 (20.4)  22.0 (19.6) 
Arithmetic mean − absolute area dense, cm2 (SD)  28.1 (26.9)  30.0 (28.4)  26.2 (25.2) 

aP < 0.05 for the difference in means between the current rotating night shift nurses and non-shift nurses.

bMissing information for age at menopause in one person with rotating night shifts and one person on day shift; age at menarche, one night shift and two day shifts; family history was missing on 2 nurses working rotating night shifts.

The mean ± SD of percentage of mammographic density were 23.2% (±20%) and the median equaled 18.4%. The mean absolute density (±SD) was 28.1 cm2 (±26.9 cm2), the median: 20.7 cm2.

Both percentage of mammographic density and absolute density were inversely associated with age (P < 0.001), the postmenopausal status (P < 0.001), BMI (P < 0.001), waist–hip ratio (P < 0.001), parity (P = 0.582), and current smoking (P < 0.05; data not shown).

There was no significant association between the current rotating night shift work and mammographic density (Table 2). The adjusted mean of percentage of mammographic density and absolute density were higher among the women working rotating night shifts than with those working day shifts, but the differences were not statistically significant [percentage mammographic density = 23.6% in nightshift nurses, 95% confidence interval (CI), 21.9%–25.4% vs. 22.5% in women working day shifts only, 95% CI, 20.8%–24.3%; absolute density = 23.9 cm2, 95% CI, 21.4–26.4 cm2 vs. 21.8 cm2, 95% CI, 19.4–24.3 cm2, respectively; Table 2]. Neither measure of mammographic density was statistically significantly related to the cumulative “exposure”—duration of night shift work, cumulative number of night shifts, and night shift hours during the entire work history. Surprisingly, whereas in postmenopausal women, the estimates were similar irrespective of the duration of night shift work; in premenopausal women, both percentage of mammographic density and absolute density tended to decrease with increasing duration of the exposure (P = 0.109 and P = 0.069; Supplementary Table S1).

Table 2.

Percentage and absolute mammographic density by selected characteristics of the rotating night shift work

Night shift work characteristicsnPercentage of mammographic density Adjusteda mean (95%CI)Absolute density, cm2 Adjusteda mean (95%CI)
Current rotating night shift 
 No 319 22.5 (20.8–24.3) 21.8 (19.4–24.3) 
 Yes 321 23.6 (21.9–25.4) 23.9 (21.4–26.4) 
P  0.62 0.25 
Total duration of night shift work, y 
 ≤5 64 22.5 (18.8–26.1) 23.3 (17.8–28.8) 
 >5–≤15 165 24.5 (22.1–27.0) 23.8 (20.3–27.2) 
 >15–≤25 206 21.5 (19.4–23.7) 21.9 (18.8–24.9) 
 >25 205 23.7 (21.4–26.0) 23.1 (20.0–26.2) 
Ptrend  0.93 0.78 
Total number of hours of night shift work by tertilesb 
 I 214 24.0 (21.8–26.1) 23.8 (20.7–26.9) 
 II 214 22.3 (20.2–24.5) 22.5 (19.5–25.5) 
 III 212 23.0 (20.7–25.2) 22.3 (19.3–25.4) 
Ptrend  0.49 0.49 
Cumulative number of night shifts    
 ≤999 185 23.8 (21.5–26.1) 23.6 (20.3–26.9) 
 1,000–1,999 225 22.5 (20.5–24.6) 22.9 (19.9–25.8) 
 2,000+ 230 23.1 (20.9–25.2) 22.3 (19.4–25.2) 
Ptrend  0.66 0.56 
Average frequency (weighted by duration); no. of night shifts/mo 
 ≤2 214 24.2 (22.0–26.3) 24.4 (21.3–27.5) 
 >2–≤3.9 213 22.3 (20.3–24.4) 22.8 (19.8–25.8) 
 >3.9 213 22.7 (20.6–24.8) 21.5 (18.6–24.4) 
Ptrend  0.33 0.18 
Total duration of reported exposure to surgical lamp, y 
 Day shifts (reference) 550 23.3 (21.9–24.6) 23.0 (21.1–24.9) 
 >0–≤10 39 21.3 (16.8–25.9) 21.1 (14.3–27.8) 
 >10 51 22.7 (18.4–26.9) 23.2 (17.1–29.4) 
Ptrend  0.61 0.92 
Night shift work characteristicsnPercentage of mammographic density Adjusteda mean (95%CI)Absolute density, cm2 Adjusteda mean (95%CI)
Current rotating night shift 
 No 319 22.5 (20.8–24.3) 21.8 (19.4–24.3) 
 Yes 321 23.6 (21.9–25.4) 23.9 (21.4–26.4) 
P  0.62 0.25 
Total duration of night shift work, y 
 ≤5 64 22.5 (18.8–26.1) 23.3 (17.8–28.8) 
 >5–≤15 165 24.5 (22.1–27.0) 23.8 (20.3–27.2) 
 >15–≤25 206 21.5 (19.4–23.7) 21.9 (18.8–24.9) 
 >25 205 23.7 (21.4–26.0) 23.1 (20.0–26.2) 
Ptrend  0.93 0.78 
Total number of hours of night shift work by tertilesb 
 I 214 24.0 (21.8–26.1) 23.8 (20.7–26.9) 
 II 214 22.3 (20.2–24.5) 22.5 (19.5–25.5) 
 III 212 23.0 (20.7–25.2) 22.3 (19.3–25.4) 
Ptrend  0.49 0.49 
Cumulative number of night shifts    
 ≤999 185 23.8 (21.5–26.1) 23.6 (20.3–26.9) 
 1,000–1,999 225 22.5 (20.5–24.6) 22.9 (19.9–25.8) 
 2,000+ 230 23.1 (20.9–25.2) 22.3 (19.4–25.2) 
Ptrend  0.66 0.56 
Average frequency (weighted by duration); no. of night shifts/mo 
 ≤2 214 24.2 (22.0–26.3) 24.4 (21.3–27.5) 
 >2–≤3.9 213 22.3 (20.3–24.4) 22.8 (19.8–25.8) 
 >3.9 213 22.7 (20.6–24.8) 21.5 (18.6–24.4) 
Ptrend  0.33 0.18 
Total duration of reported exposure to surgical lamp, y 
 Day shifts (reference) 550 23.3 (21.9–24.6) 23.0 (21.1–24.9) 
 >0–≤10 39 21.3 (16.8–25.9) 21.1 (14.3–27.8) 
 >10 51 22.7 (18.4–26.9) 23.2 (17.1–29.4) 
Ptrend  0.61 0.92 

aAdjustment for age, BMI, menopausal status, age at menopause, age at menarche, smoking, and season of the year.

bI tertile, ≤13,056 hours; II tertile, >13,056 to ≤24,304 hours; and III tertile, >24,304 hours.

There were no statistically significant associations between the current rotating night shift characteristics and percentage or absolute mammographic density (Table 3). Absolute density was 2.4 cm2 higher in women who reported to be currently working 8 or more night shifts per month than in those only working dayshifts and 2.5 cm2 higher in women who worked effectively more than 10 hours during night shifts than in those working dayshifts only, however, neither of these results was statistically significant. The reported exposure to light at the current job was not associated with mammographic density. We noted that in women who reported assisting in operations or deliveries at night, the mammographic density measures were higher than the reference group, but they were not statistically significantly.

Table 3.

Percentage of mammographic density and absolute density by selected characteristics of the rotating night shift work

Current rotating night shift work characteristicsnPercentage of density Adjusteda mean (95%CI)Absolute density, cm2 Adjusteda mean (95%CI)
Current night shift work frequency per month    
 Day shifts (reference) 319 22.5 (20.8–24.3) 21.8 (19.4–24.3) 
 2–7 nights 285 23.6 (21.8–25.5) 23.9 (21.2–26.5) 
 8+ nights 36 23.7 (18.4–29.0) 24.2 (16.7–31.7) 
P  0.40 0.27 
Night shifts working hours,c   
 Day shifts (reference) 319 22.5 (20.7–24.2) 21.8 (19.4–24.2) 
 <10 84 23.2 (19.9–26.5) 22.7 (18.0–27.4) 
 ≥10–14 230 23.8 (21.7–25.9) 24.3 (21.3–27.3) 
P  0.34 0.20 
Light at workc    
 Day shifts (reference) 319 22.5 (20.7–24.2) 21.8 (19.4–24.2) 
 Dim 139 23.0 (20.4–25.6) 23.0 (19.3–26.7) 
 Full light 140 24.4 (21.8–27.1) 25.1 (21.2–28.9) 
 Surgical lamp 35 22.8 (17.7–28.0) 22.8 (15.3–30.2) 
Ptrend  0.34 0.24 
Activities at work during the night shiftc    
 Day shifts (reference) 319 22.5 (20.7–24.2) 21.8 (19.4–24.2) 
 1b 23 26.8 (19.9–33.7) 25.4 (15.9–35.0) 
 1 and 2 or 2 221 23.1 (21.1–25.2) 23.3 (20.4–26.3) 
 Any combination with 3 70 24.1 (20.4–27.8) 25.1 (19.6–30.6) 
Ptrend  0.43 0.24 
Current rotating night shift work characteristicsnPercentage of density Adjusteda mean (95%CI)Absolute density, cm2 Adjusteda mean (95%CI)
Current night shift work frequency per month    
 Day shifts (reference) 319 22.5 (20.8–24.3) 21.8 (19.4–24.3) 
 2–7 nights 285 23.6 (21.8–25.5) 23.9 (21.2–26.5) 
 8+ nights 36 23.7 (18.4–29.0) 24.2 (16.7–31.7) 
P  0.40 0.27 
Night shifts working hours,c   
 Day shifts (reference) 319 22.5 (20.7–24.2) 21.8 (19.4–24.2) 
 <10 84 23.2 (19.9–26.5) 22.7 (18.0–27.4) 
 ≥10–14 230 23.8 (21.7–25.9) 24.3 (21.3–27.3) 
P  0.34 0.20 
Light at workc    
 Day shifts (reference) 319 22.5 (20.7–24.2) 21.8 (19.4–24.2) 
 Dim 139 23.0 (20.4–25.6) 23.0 (19.3–26.7) 
 Full light 140 24.4 (21.8–27.1) 25.1 (21.2–28.9) 
 Surgical lamp 35 22.8 (17.7–28.0) 22.8 (15.3–30.2) 
Ptrend  0.34 0.24 
Activities at work during the night shiftc    
 Day shifts (reference) 319 22.5 (20.7–24.2) 21.8 (19.4–24.2) 
 1b 23 26.8 (19.9–33.7) 25.4 (15.9–35.0) 
 1 and 2 or 2 221 23.1 (21.1–25.2) 23.3 (20.4–26.3) 
 Any combination with 3 70 24.1 (20.4–27.8) 25.1 (19.6–30.6) 
Ptrend  0.43 0.24 

aAdjustment for age, BMI, menopausal status, age at menopause, age at menarche, smoking, and season of the year.

bCategories of the activities: 1, taking care of patients, injections, administering pills; 2, small interventions; and 3, assistance in operations (deliveries).

cMissing information for 7 women.

None of the examined associations were modified by the menopausal status, with similar null findings both in pre- and postmenopausal women (Supplementary Tables S1 and S2)

Finally, we explored the potential association between the morning MT6s level and mammographic density, with no significant relationships found (Table 4). We also tested these associations among pre- and postmenopausal women separately, with no relationships observed in each subgroup (Supplementary Table S3). Assuming the potential for acute and reversible disturbance of the diurnal rhythm of melatonin synthesis by a night shift, we repeated the same analysis among women working during the days, only to find similar results (data not shown). We also tested the potential associations including the time between mammography and urine collection. The results did not change substantially (data not shown).

Table 4.

Percentage and absolute mammographic density by morning MT6s levels

Morning MT6sb
Q1 (n = 160)Q2 (n = 160)Q3 (n = 160)Q4 (n = 160)P
Percent mammographic density [adjusteda mean (95%CI)] 22.6 (20.1–25.1) 23.1 (20.7–25.6) 23.2 (20.8–25.5) 23.4 (21.0–25.9) 0.65 
Absolute density [adjusteda mean (95%CI)] 21.8 (18.3–25.2) 22.8 (19.3–26.2) 23.0 (19.6–26.4) 23.9 (20.3–27.4) 0.42 
Morning MT6sb
Q1 (n = 160)Q2 (n = 160)Q3 (n = 160)Q4 (n = 160)P
Percent mammographic density [adjusteda mean (95%CI)] 22.6 (20.1–25.1) 23.1 (20.7–25.6) 23.2 (20.8–25.5) 23.4 (21.0–25.9) 0.65 
Absolute density [adjusteda mean (95%CI)] 21.8 (18.3–25.2) 22.8 (19.3–26.2) 23.0 (19.6–26.4) 23.9 (20.3–27.4) 0.42 

aAdjustment for age, BMI, menopausal status, age at menopause, age at menarche, smoking, and season of the year when mammography was conducted.

bQuartile ranges: Q1, ≤25.04 ng/mgCr; Q2, >25.04 to ≤42.42 ng/mgCr; Q3, >42.42 to ≤67.52 ng/mgCr; and Q4, >67.52 ng/mgCr.

In this study, we investigated cross-sectionally the association between rotating night shift work and mammographic density in the population of 640 nurses and midwives. We did not observe any statistically significant associations, neither when the current rotating night shift work characteristics nor when the cumulative history of night shift work were examined. We did not observe any relationships between morning MT6s levels and mammographic density, neither in the total population nor in pre- or postmenopausal women.

We found slightly higher percentage of mammographic density and absolute density in women working rotating night shifts than in day workers. The contrast to day workers was particularly observed for nurses with 8 or more night shifts per month and nurses with night shifts of ≥10 effective working hours. However, the effects were small and not statistically significant. We did not find any significant increase in mammographic density in women who reported exposure to surgical lamps at their job or who assisted in operations or deliveries, which served as a proxy for light exposure at night.

The epidemiologic evidence on the association between night shift work and breast cancer risk has been mounting since the first report on the significant 50% increase of breast cancer risk in radio and telegraph operators in Norway was published (8). Several reviews have been conducted in the recent years (35–37) and a meta-analysis of the data conducted by Erren and colleagues (37) indicated that the risk of developing breast cancer may be increased by 70% in flight attendants and 40% in night shift workers. Increased breast cancer risk has been observed among nurses in United States (2), Norway (4, 5), Denmark (9) and other Nordic countries (38), and France (39), with the adjusted breast cancer risk up to almost 3-fold in the subgroup of Danish nurses working permanent night shifts in addition to rotating nights or day work when compared with day workers but also with a significant increase observed in rotating night nurses (OR, 1.8; ref. 9). Interestingly, the highest incidence of male breast cancer has been observed in shift or night shift work occupations in a large registry–based Nordic cohort (38). Some studies reported associations with breast cancer after long-term night shift work (≥20–30 years; refs. 2, 4, 13). In other researches, statistically significant increases have been observed after a relatively short duration of night shift work, that is, 5 to 10 years of working after midnight in Danish nurses, with OR = 2.3 (9), or more than 5 years (of ≥6 consecutive nights) with OR = 1.8 (5).

Our study, to our best knowledge, has been the first one to investigate the association between night shift work and mammographic density. The hypothesis we investigated linked occupational exposure and night shift work to mammographic density, with insight into melatonin synthesis disruption as a potential mediating factor. Melatonin receptors have been found on both ovaries and the hypothalamus, suggesting that it may interfere with the function of gonads and the gonado-hypothalamic axis (40). As shown in some experiments, it downregulates aromatase expression—an enzyme that converts androgens to estrogens (41)—and it also downregulates the transcription of the estrogen receptor (ER)α, resulting in the reduction of estrogen-related transcriptional activation (42). The data on the relationship between melatonin and sex hormones are inconsistent; nevertheless, in some studies, such relationships have been observed (43–45). The uncertainty also remains about the association between circulating estradiol and mammographic density. The associations between mammographic density and hormone-related breast cancer risk factors suggest the role of estrogens. However, the data on the link between circulating estradiol and mammographic density have been inconsistent so far (46–53).

Only one study so far has examined the links between morning MT6s and mammographic density (54) with no evidence found of an inverse association between these 2 markers. Interestingly, in the same study on Japanese women, a positive relationship between morning melatonin and mammographic density has been found in premenopausal women. The authors suggested that these findings might have been explained by the differentiation of breast cells promoted by melatonin (42). However, if melatonin is to exert the antiestrogenic action, one would have expected a decrease, not an increase in mammographic density (55–58).

The “night shift work exposure” in the population we studied was characterized by its intermittent character. The majority of the nurses working rotating night shifts in our study had been working 12-hour shifts, starting at 7 pm and ending at 7 am. This system has been operating at the hospitals in Poland since 1999. The results of our study may indicate that no risk of developing higher mammographic density is conferred by rotating night shift work or that the risk associated with such work is relatively small. We had 80% statistical power to detect a 3.5% difference in percentage of mammographic density between the groups. The increases in breast cancer risk observed among rotating night shift nurses have varied, showing a 35% increase in women having worked rotating night shifts for longer than 30 years in the Nurses Health Study (NHS; ref. 2), up to more than 2-fold in Norwegian nurses with more than 20 years of night shift work history (4). As shown by Boyd and colleagues, a 1% difference in mammographic density is associated with a 2% increase in breast cancer risk (59). It could be thus speculated that if an increase in breast cancer risk was solely mediated by an increase in mammographic density, then the expected increase in percentage of mammographic density in nurses after 20 years of night shift work would be approximately 17% to 40%. We did not however observe any positive relationship between mammographic density and the duration of night shift work. Percentage of mammographic density in women with the duration of night shift work longer than 25 years was by 1.2% higher than in women with the night shift work duration shorter than 5 years.

The strength of this study is that it was conducted in a well-characterized population of women. As observed by other authors, nurses represent a reliable population, with usually higher participation rates and better recall than that of the general population. The response rate was relatively high with 95% mammographies conducted in the total population of women who agreed to participate in our study project. Another strength is the use of a continuous measure of mammographic density. We showed high levels of reproducibility for density readings (98%). Of the well-established associations for mammographic density, our findings confirmed inverse relationships with age, postmenopausal status, higher BMI, and waist–hip ratio. These findings support the validity of the mammography data we collected in this study.

A potential limitation of our study relates to timing of the MT6s and mammography. The average time between the urine samples collection and mammography was 120 days. We collected spot morning urine samples and determined MT6s (creatinine-adjusted), which has been recognized as a valid predictor of overnight or peak melatonin synthesis (60, 61). In our previous analysis, we had not observed a significant individual variability between the morning MT6s measurements on 2 subsequent days, based on the comparison in 23 pairs of the samples from women in the pilot phase of the study (31). Arendt has shown that the 24-hour melatonin rhythm is reproducible over a 2-week period (62). Seasonal variations of mammographic density have been suggested for premenopausal women in one study (63). If the stability of markers we analyzed over the period of several months was weak, then our analysis might have been inadequate, due to seasonal variation of both measures. In our study, we did not note a significant association between the season of the year and MT6s, and we adjusted for the season of mammography.

In summary, this study found no evidence that rotating night shift work is associated with an increase in mammographic density or that the urinary MT6s levels of melatonin are inversely associated with mammographic density. Thus, it is unlikely that the development of breast cancer in nurses working rotating night shifts observed by other researchers is mediated by an increase in mammographic density.

No potential conflicts of interest were disclosed.

Conception and design: B. Peplonska, E. Reszka, J.A. Lie, H. Kjuus

Development of methodology: B. Peplonska, E. Reszka, J. Gromadzinska, J.A. Lie, H. Kjuus

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): B. Peplonska, A. Bukowska

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): B. Peplonska, W. Sobala, W. Wasowicz, G. Ursin

Writing, review, and/or revision of the manuscript: B. Peplonska, A. Bukowska, W. Sobala, E. Reszka, W. Wasowicz, J.A. Lie, H. Kjuus, G. Ursin

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): A. Bukowska

Study supervision: B. Peplonska, H. Kjuus

Assessed mammographic density: G. Ursin

The authors thank the Regional Registry of the Nurses and Midwives in Lodz, and in particular Grazyna Romanowska for her help in organizing this study. They also thank the interviewers and all nurses and midwives for their participation in this project.

This project is supported by a grant from the Polish-Norwegian Research Fund (PNRF 243-AI-1/07) and ECNIS2 (7PR/2011/266198).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
IARC
Monographs on the Evaluation of Carcinogenic Risk to Humans
,
Volume 98
,
Painting, Firefighting and Shiftwork.
Lyon, France
, 
2010
.
2.
Schernhammer
ES
,
Laden
F
,
Speizer
FE
,
Willett
WC
,
Hunter
DJ
,
Kawachi
I
, et al
Rotating night shifts and risk of breast cancer in women participating in the nurses' health study
.
J Natl Cancer Inst
2001
;
93
:
1563
8
.
3.
Schernhammer
ES
,
Kroenke
CH
,
Laden
F
,
Hankinson
SE
. 
Night work and risk of breast cancer
.
Epidemiology
2006
;
17
:
108
11
.
4.
Lie
JA
,
Roessink
J
,
Kjaerheim
K
. 
Breast cancer and night work among Norwegian nurses
.
Cancer Causes Control
2006
;
17
:
39
44
.
5.
Lie
JA
,
Kjuus
H
,
Zienolddiny
S
,
Haugen
A
,
Stevens
RG
,
Kjaerheim
K
. 
Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics
.
Am J Epidemiol
2011
;
173
:
1272
9
.
6.
Hansen
J
. 
Increased breast cancer risk among women who work predominantly at night
.
Epidemiology
2001
;
12
:
74
7
.
7.
Davis
S
,
Mirick
DK
,
Stevens
RG
. 
Night shift work, light at night, and risk of breast cancer
.
J Natl Cancer Inst
2001
;
93
:
1557
62
.
8.
Tynes
T
,
Hannevik
M
,
Andersen
A
,
Vistnes
AI
,
Haldorsen
T
. 
Incidence of breast cancer in Norwegian female radio and telegraph operators
.
Cancer Causes Control
1996
;
7
:
197
204
.
9.
Hansen
J
,
Stevens
RG
. 
Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems
.
Eur J Cancer
. 
2011 Aug 6
.
[Epub ahead of print]
.
10.
O'Leary
ES
,
Schoenfeld
ER
,
Stevens
RG
,
Kabat
GC
,
Henderson
K
,
Grimson
R
, et al
Shift work, light at night, and breast cancer on Long Island, New York
.
Am J Epidemiol
2006
;
164
:
358
66
.
11.
Schwartzbaum
J
,
Ahlbom
A
,
Feychting
M
. 
Cohort study of cancer risk among male and female shift workers
.
Scand J Work Environ Health
2007
;
33
:
336
43
.
12.
Pronk
A
,
Ji
BT
,
Shu
XO
,
Xue
S
,
Yang
G
,
Li
HL
, et al
Night-shift work and breast cancer risk in a cohort of Chinese women
.
Am J Epidemiol
2010
;
171
:
953
9
.
13.
Pesch
B
,
Harth
V
,
Rabstein
S
,
Baisch
C
,
Schiffermann
M
,
Pallapies
D
, et al
Night work and breast cancer - results from the German GENICA study
.
Scand J Work Environ Health
2010
;
36
:
134
41
.
14.
Stevens
RG
. 
Circadian disruption and breast cancer: from melatonin to clock genes
.
Epidemiology
2005
;
16
:
254
8
.
15.
Stevens
RG
. 
Artificial lighting in the industrialized world: circadian disruption and breast cancer
.
Cancer Causes Control
2006
;
17
:
501
7
.
16.
Schernhammer
ES
,
Schulmeister
K
. 
Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?
Br J Cancer
2004
;
90
:
941
3
.
17.
Schernhammer
ES
,
Berrino
F
,
Krogh
V
,
Secreto
G
,
Micheli
A
,
Venturelli
E
, et al
Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women
.
J Natl Cancer Inst
2008
;
100
:
898
905
.
18.
Schernhammer
ES
,
Berrino
F
,
Krogh
V
,
Secreto
G
,
Micheli
A
,
Venturelli
E
, et al
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort
.
Cancer Epidemiol Biomarkers Prev
2010
;
19
:
729
37
.
19.
Schernhammer
ES
,
Hankinson
SE
. 
Urinary melatonin levels and breast cancer risk
.
J Natl Cancer Inst
2005
;
97
:
1084
7
.
20.
Schernhammer
ES
,
Hankinson
SE
. 
Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort
.
Cancer Epidemiol Biomarkers Prev
2009
;
18
:
74
9
.
21.
Travis
RC
,
Allen
DS
,
Fentiman
IS
,
Key
TJ
. 
Melatonin and breast cancer: a prospective study
.
J Natl Cancer Inst
2004
;
96
:
475
82
.
22.
Cos
S
,
Sanchez-Barcelo
EJ
. 
Melatonin and mammary pathological growth Front
.
Neuroendocrinol
2000
;
21
:
133
70
.
23.
Pandi-Perumal
SR
,
Srinivasan
V
,
Maestroni
GJ
,
Cardinali
DP
,
Poeggeler
B
,
Hardeland
R
. 
Melatonin: nature's most versatile biological signal?
FEBS J
2006
;
273
:
2813
38
.
24.
Boyd
NF
,
Martin
LJ
,
Yaffe
MJ
,
Minkin
S
. 
Mammographic density: a hormonally responsive risk factor for breast cancer
.
J Br Menopause Soc
2006
;
12
:
186
93
.
25.
McCormack
VA
,
dos
SS
 I
. 
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis
.
Cancer Epidemiol Biomarkers Prev
2006
;
15
:
1159
69
.
26.
Craig
CL
,
Marshall
AL
,
Sjostrom
M
,
Bauman
AE
,
Booth
ML
,
Ainsworth
BE
, et al
International physical activity questionnaire: 12-country reliability and validity
.
Med Sci Sports Exerc
2003
;
35
:
1381
95
.
27.
Buysse
DJ
,
Reynolds
CF
 III
,
Monk
TH
,
Berman
SR
,
Kupfer
DJ
. 
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
.
Psychiatry Res
1989
;
28
:
193
213
.
28.
Ursin
G
. 
[Mammographic density as indicator of breast cancer risk]
.
Tidsskr Nor Laegeforen
2003
;
123
:
3373
6
.
29.
Ursin
G
,
Astrahan
MA
,
Salane
M
,
Parisky
YR
,
Pearce
JG
,
Daniels
JR
, et al
The detection of changes in mammographic densities
.
Cancer Epidemiol Biomarkers Prev
1998
;
7
:
43
7
.
30.
Breast Imaging Reporting and Data System (BI-RADS)
.
Reston, VA
:
American College of Radiology
; 
1998
.
31.
Peplonska
B
,
Bukowska
A
,
Gromadzinska
J
,
Sobala
W
,
Reszka
E
,
Lie
JA
, et al
Night shift work characteristics and 6-sulfatoxymelatonin(MT6s) in rotating night shift nurses and midwives
.
Occup Environ Med
2012
;
69
:
339
46
.
32.
Ferrari
SLP
,
Cribari-Neto
F
. 
Beta regression for modelling rates and proportions
.
J Appl Stat
2004
;
31
:
799
815
.
33.
Akaike
H
. 
A new look at the statistical model identification
.
IEEE Trans Autom Control
1974
;
19
:
716
23
.
34.
Rothman
KJ
,
Greenland
S
. 
Modern epidemiology. 2nd ed
.
Lippincott Williams and Wilkins
,
Philadelphia
, 
1998
.
35.
Brudnowska
J
,
Peplonska
B
. 
[Night shift work and risk of cancer–a literature review]
.
Med Pr
2011
;
62
:
323
38
.
36.
Costa
G
,
Haus
E
,
Stevens
R
. 
Shift work and cancer - considerations on rationale, mechanisms, and epidemiology
.
Scand J Work Environ Health
2010
;
36
:
163
79
.
37.
Erren
TC
,
Pape
HG
,
Reiter
RJ
,
Piekarski
C
. 
Chronodisruption and cancer
.
Naturwissenschaften
2008
;
95
:
367
82
.
38.
Pukkala
E
,
Martinsen
JI
,
Lynge
E
,
Gunnarsdottir
HK
,
Sparen
P
,
Tryggvadottir
L
, et al
Occupation and cancer - follow-up of 15 million people in five Nordic countries
.
Acta Oncol
2009
;
48
:
646
790
.
39.
Villeneuve
S
,
Fevotte
J
,
Anger
A
,
Truong
T
,
Lamkarkach
F
,
Gaye
O
, et al
Breast cancer risk by occupation and industry: analysis of the CECILE study, a population-based case-control study in France
.
Am J Ind Med
2011
;
54
:
499
509
.
40.
Ekmekcioglu
C
. 
Melatonin receptors in humans: biological role and clinical relevance
.
Biomed Pharmacother
2006
;
60
:
97
108
.
41.
Cos
S
,
Martinez-Campa
C
,
Mediavilla
MD
,
Sanchez-Barcelo
EJ
. 
Melatonin modulates aromatase activity in MCF-7 human breast cancer cells
.
J Pineal Res
2005
;
38
:
136
42
.
42.
Cos
S
,
Gonzalez
A
,
Martinez-Campa
C
,
Mediavilla
MD
,
onso-Gonzalez
C
,
Sanchez-Barcelo
EJ
. 
Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
.
Cancer Detect Prev
2006
;
30
:
118
28
.
43.
Schernhammer
ES
,
Kroenke
CH
,
Dowsett
M
,
Folkerd
E
,
Hankinson
SE
. 
Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels
.
J Pineal Res
2006
;
40
:
116
24
.
44.
Pawlikowski
M
,
Kolomecka
M
,
Wojtczak
A
,
Karasek
M
. 
Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women
.
Neuro Endocrinol Lett
2002
;
23
Suppl 1
:
17
9
.
45.
Okatani
Y
,
Morioka
N
,
Wakatsuki
A
. 
Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations
.
J Pineal Res
2000
;
28
:
111
8
.
46.
Tamimi
RM
,
Byrne
C
,
Colditz
GA
,
Hankinson
SE
. 
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women
.
J Natl Cancer Inst
2007
;
99
:
1178
87
.
47.
Aiello
EJ
,
Tworoger
SS
,
Yasui
Y
,
Stanczyk
FZ
,
Potter
J
,
Ulrich
CM
, et al
Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women
.
Cancer Epidemiol Biomarkers Prev
2005
;
14
:
1411
7
.
48.
Greendale
GA
,
Palla
SL
,
Ursin
G
,
Laughlin
GA
,
Crandall
C
,
Pike
MC
, et al
The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study
.
Am J Epidemiol
2005
;
162
:
826
34
.
49.
Johansson
H
,
Gandini
S
,
Bonanni
B
,
Mariette
F
,
Guerrieri-Gonzaga
A
,
Serrano
D
, et al
Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women
.
Breast Cancer Res Treat
2008
;
108
:
57
67
.
50.
Boyd
N
,
Martin
L
,
Stone
J
,
Little
L
,
Minkin
S
,
Yaffe
M
. 
A longitudinal study of the effects of menopause on mammographic features
.
Cancer Epidemiol Biomarkers Prev
2002
;
11
:
1048
53
.
51.
Greendale
GA
,
Huang
MH
,
Ursin
G
,
Ingles
S
,
Stanczyk
F
,
Crandall
C
, et al
Serum prolactin levels are positively associated with mammographic density in postmenopausal women
.
Breast Cancer Res Treat
2007
;
105
:
337
46
.
52.
Walker
K
,
Fletcher
O
,
Johnson
N
,
Coupland
B
,
McCormack
VA
,
Folkerd
E
, et al
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors
.
Cancer Res
2009
;
69
:
6490
9
.
53.
McCormack
VA
,
Dowsett
M
,
Folkerd
E
,
Johnson
N
,
Palles
C
,
Coupland
B
, et al
Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women
.
Breast Cancer Res
2009
;
11
:
R38
.
54.
Nagata
C
,
Matsubara
T
,
Hara
T
,
Fujita
H
,
Nagao
Y
,
Yamamoto
S
, et al
Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women
.
Cancer Epidemiol Biomarkers Prev
2007
;
16
:
2509
12
.
55.
Atkinson
C
,
Warren
R
,
Bingham
SA
,
Day
NE
. 
Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen
.
Cancer Epidemiol Biomarkers Prev
1999
;
8
:
863
6
.
56.
Cuzick
J
,
Warwick
J
,
Pinney
E
,
Duffy
SW
,
Cawthorn
S
,
Howell
A
, et al
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study
.
J Natl Cancer Inst
2011
;
103
:
744
52
.
57.
Greendale
GA
,
Reboussin
BA
,
Slone
S
,
Wasilauskas
C
,
Pike
MC
,
Ursin
G
. 
Postmenopausal hormone therapy and change in mammographic density
.
J Natl Cancer Inst
2003
;
95
:
30
7
.
58.
Stuedal
A
,
Ma
H
,
Bjorndal
H
,
Ursin
G
. 
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women
.
Climacteric
2009
;
12
:
248
58
.
59.
Boyd
NF
,
Byng
JW
,
Jong
RA
,
Fishell
EK
,
Little
LE
,
Miller
AB
, et al
Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study
.
J Natl Cancer Inst
1995
;
87
:
670
5
.
60.
Hsing
AW
,
Meyer
TE
,
Niwa
S
,
Quraishi
SM
,
Chu
LW
. 
Measuring serum melatonin in epidemiologic studies
.
Cancer Epidemiol Biomarkers Prev
2010
;
19
:
932
7
.
61.
Graham
C
,
Cook
MR
,
Kavet
R
,
Sastre
A
,
Smith
DK
. 
Prediction of nocturnal plasma melatonin from morning urinary measures
.
J Pineal Res
1998
;
24
:
230
8
.
62.
Arendt
J
. 
Melatonin
.
Clin Endocrinol (Oxf)
1988
;
29
:
205
29
.
63.
Brisson
J
,
Berube
S
,
Diorio
C
,
Sinotte
M
,
Pollak
M
,
Masse
B
. 
Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin D
.
Cancer Epidemiol Biomarkers Prev
2007
;
16
:
929
33
.